Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. NJPS [इंटर्नेट]. 31 दिसम्बर, 2025 [उल्लेखित 14 अप्रैल, 2026];40(2):251-62. पर उपलब्ध: https://www.ojshostng.com/index.php/njphysiologicalsciences/article/view/4001